The aim of the current study is to assess the predictive value of renal cell arrest biomarkers (urinary TIMP2 and IGFBP7), renal damage biomarkers (urinary KIM-1) and microscopic examination of urinary sediment in progression and outcome of sepsis associated AKI.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Urinary TIMP2 and IGFBP7 estimation
Timeframe: 90 days
Urinary KIM-1 estimation
Timeframe: 90 days
Examination of urine sediment
Timeframe: 7 days
progression of AKI
Timeframe: 90 days
Examination of urine sediment
Timeframe: 7 days